Fact CheckerSign in

NCT06529861Not yet recruiting

Mechanisms Behind Microvascular Dysfunction in INOCA

Identification of Mechanisms Behind Microvascular Dysfunction in Ischemia With No Obstructive Coronary Artery Disease

Source: ClinicalTrials.gov · Last updated 31 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of the study is to identify the causes of chest pain in patients experiencing chest pain with no signs of narrowing in the coronary arteries of the heart.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
8 Jul 2024
Start date
1 Oct 2024
Primary completion date
30 Oct 2027
Lead sponsor
Bispebjerg Hospital
NCT number
NCT06529861

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 1 Oct 2024 to the primary completion date, 30 Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled hypertension defined as blood pressure above target 140/90 for all
  • The subject has a known allergy to either: norepinephrine, adenosine, ketorolac, and or ascorbic acid (vitamin C).

Lab values

  • Heart failure, defined as left ventricular ejection fraction of less than 40%

Other

  • Females of childbearing potential (defined as a premeno-pausal female capable of becoming pregnant). The female patient must either be postmenopausal, defined as amen-orrhea for at least 1 year, or surgically sterile
  • Co-morbidity resulting in \<1 year expected survival
  • Considered by the investigator, for any reason, to be an unsuitable candidate for the study.
  • Unable or unwilling to exercise, e.g. due to arthritis or injury\*
  • Already are regularly physically active and/or have a maximal oxygen uptake \>45 ml/kg/min

Who the study is looking for

  • Only for angina patients: Have CMD, defined as myocardial bloodflow re-serve (MBFR) \< 2.5 or hyperemic myocardial blood flow (hMBF) \< 2.3ml/g/min

Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57, Frederiksberg, Denmark, 2000
Coordinator of this site? Confirm its status
CopenhagenDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.